January 17, 2007 11:41 ET

RxNT Releases Statement Supporting National eRx Initiative

ANNAPOLIS, MD -- (MARKET WIRE) -- January 17, 2007 -- RxNT, the nation's leader in electronic prescribing, supports the concept of the National E-Prescribing Patient Safety Initiative (NEPSI) and will continue to advocate the adoption of electronic prescribing to increase patient safety, streamline medical costs, and to enable providers to practice excellent medicine. RxNT celebrates the expansion of awareness and increased commitment to e-prescribing solutions.

"We feel this announcement will serve as a catalyst to accelerate the adoption of technology across our healthcare system to meet the needs of our communities," states Randy Boldyga, President and CEO of RxNT.

Although RxNT views NEPSI as a great first step to advance technology across the healthcare industry, RxNT points out that the flaw in the NEPSI model is that health benefit companies and regional payers, who will most likely provide physician-incentives to stimulate adoption for this initiative, might find it difficult to invest in an initiative having only one affiliated electronic prescribing vendor. For the past 7 years RxNT has been an advocate of the multi-vendor model because we recognize that what works for one physician group may not always work for another, leaving medical centers and physicians frustrated with the lack of vendor selection and health plans unhappy with low levels of adoption.

About RxNT

RxNT is a national electronic prescription provider located in Annapolis, Maryland. Our high-caliber product reinforces patient safety by reducing error, drug incompatibility issues, and illegibility. RxNT can be found at or for more information please call us toll free at 800-943-RXNT.

Contact Information